June 24, 2026 ZILLOW STOCKHOLDER REMINDER: Bragar Eagel & Squire, P.C. Reminds Zillow Group, Inc. Investors of the August 10th Lead Plaintiff Deadline and Urges Investors to Contact the Firm
June 24, 2026 European Commission Approves KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) as First PD-1 Inhibitor Plus Antibody-Drug Conjugate Regimen for Adults With Cisplatin-Ineligible Resectable Muscle-Invasive Bladder Cancer